home libri books Fumetti ebook dvd top ten sconti 0 Carrello


Torna Indietro

williams ph.d. lawrence e. - radiopharmaceuticals

Radiopharmaceuticals Introduction to Drug Evaluation and Dose Estimation




Disponibilità: Normalmente disponibile in 20 giorni
A causa di problematiche nell'approvvigionamento legate alla Brexit sono possibili ritardi nelle consegne.


PREZZO
55,98 €
NICEPRICE
53,18 €
SCONTO
5%



Questo prodotto usufruisce delle SPEDIZIONI GRATIS
selezionando l'opzione Corriere Veloce in fase di ordine.


Pagabile anche con Carta della cultura giovani e del merito, 18App Bonus Cultura e Carta del Docente


Facebook Twitter Aggiungi commento


Spese Gratis

Dettagli

Genere:Libro
Lingua: Inglese
Editore:

CRC Press

Pubblicazione: 06/2020
Edizione: 1° edizione





Note Editore

Nanoengineering, energized by the desire to find specific targeting agents, is leading to dramatic acceleration in novel drug design. However, in this flurry of activity, some issues may be overlooked. This is especially true in the area of determining dosage and evaluating the effects of multiple agents designed to target more than one site of metastasis.Offering the unique perspective of a medical physicist who has worked directly with cancer patients for over three decades, Radiopharmaceuticals: Introduction to Drug Evaluation and Dose Estimation starts by exploring the recent history and current state of the field. Then, citing key research and practical examples, the author looks at how to run studies and employ estimation and evaluation methods that lead to the best multiple agents with the least amount of trial and error. He discusses methods that will allow researchers to more rigorously:Differentiate one radiopharmaceutical (RP) from anotherEstimate radiation doses Correlate results across various species to realize more informed data from clinical trialsIncorporating developments in nanotechnology and radiology, with the ultimate goal of achieving personalized patient-specific treatment, this book crosses disciplines to addresses a range of topics including:Preclinical RP developmentOrganization of clinical trials Determination of activity in vivo Modeling and temporal integration with a look at the mass law for tumor uptake as a function of tumor size (discovered by the author) Absorbed dose estimates with and without clinical correlations Multiple-modality therapyDr. Lawrence Williams has devoted most of his life’s research to tumor detection and treatment, and his discoveries continue to influence evolving therapies. As s a medical physicist, he is eminently qualified to bring unique insight into the discussion of radiopharmaceutical dosage rates and efficacy.




Sommario

Tumor Targeting and a Problem of Plenty. Preclinical Development of Radiopharmaceuticals and Planning of Clinical Trials. Selection of Radiopharmaceuticals for Clinical Trials. Absorbed Dose Estimation and Measurement. Determination of Activity In Vivo. Modeling and Temporal Integration. Functions Used to Determine Absorbed Dose Given Activity Integrals. Absorbed Dose Estimates without Clinical Correlations. Dose Estimates and Correlations with Laboratory and Clinical Results. Multiple-Modality Therapy of Tumors. Allometry (Of Mice and Men). Summary of Radiopharm-aceuticals and Dose Estimation. Index.




Autore

Lawrence E. Williams, Ph.D., is a professor of radiology and an imaging physicistat City of Hope National Medical Center in Duarte, California. In addition, he is anadjunct professor of radiology at University of California–Los Angeles (UCLA).While in high school, he was one of 40 national winners of the Westinghouse (nowIntel) Science Talent Search. Dr. Williams obtained his B.S. from Carnegie MellonUniversity and his M.S. and Ph.D. degrees (both in physics) from the University ofMinnesota, where he was a National Science Foundation (NSF) fellow. His initialgraduate training was in nuclear reactions at Minnesota, where he demonstratedexcited states of the mass-4 system (4He*). He later extended this work by findingexcited levels of mass-3 nuclides while working at the Rutherford High EnergyLaboratory in England. Since obtaining the National Institutes of Health (NIH) supportto become a medical physicist, Dr. Williams has devoted most of his research totumor detection and treatment and has written approximately 250 total publicationsas well as a number of patents in nuclear imaging and radionuclide therapy. He is acoauthor of Biophysical Science (Prentice Hall, 1979) and editor of Nuclear MedicinePhysics (CRC Press, 1987). He has been a grant and site reviewer for NIH since themid-1990s. Dr. Williams is associate editor of Medical Physics and a reviewer forseveral other journals. He is a member of the American Association of Physicistsin Medicine (AAPM), the Society of Nuclear Medicine, the New York Academy ofSciences, Sigma Xi, Society of Imaging Informatics in Medicine (SIIM), and theSociety of Breast Imaging. Dr. Williams has received a lifetime service award fromthe American Board of Radiology.Among Dr. Williams’ most significant biophysical discoveries is the mass-lawfor tumor uptake as a function of tumor size. He was also codiscoverer (with RichardProffitt) of tumor targeting with liposomes. This work involved one of the first applications of normal organ blockage by use of an unlabeled agent—that is, a two-stepprocess. Dr. Williams has developed a pair of indices for quantifying the ability of aradiopharmaceutical to permit imaging or therapy of lesions in animals or patients. Hehas also demonstrated that radioactive decay must be considered inherently as one possible exit route in modeling analysis of radioactive drugs. With his colleagues at City of Hope, Dr. Williams measured and calculated the brake radiation dose result for a source of 90Y in a humanoid phantom. This study remains as one of the few examples of a comparison of dose estimates and measurement in the nuclear medicine literature.










Altre Informazioni

ISBN:

9780367577056

Condizione: Nuovo
Dimensioni: 9.25 x 6.25 in Ø 1.33 lb
Formato: Brossura
Pagine Arabe: 326


Dicono di noi